長期投資家のためのIR情報
バリュートレンド

【7446】東北化学薬品
化学工業薬品、臨床検査試薬。
類似企業:
【業界1位】 ユアサ商事
【売上同水準】 ナ・デックス オータケ

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2024.09 2024/08/01 Q3予 32,300 0.0% 0.0% 440 0.0% 0.0% 490 0.0% 0.0% 320 0.0% 0.0%
2024.09 2024/05/01 Q2予 32,300 0.0% 0.0% 440 0.0% 0.0% 490 0.0% 0.0% 320 0.0% 0.0%
2024.09 2024/02/01 Q1予 32,300 0.0% 0.0% 440 0.0% 0.0% 490 0.0% 0.0% 320 0.0% 0.0%
2024.09 2023/11/13 当初予 32,300 - - - 440 - - - 490 - - - 320 - - -
2023.09 2023/11/13 35,094 +0.3% +0.3% 750 +27.1% +27.1% 808 +26.2% +26.2% 556 +32.4% +32.4%
2023.09 2023/08/01 Q3予 35,000 0.0% 0.0% 590 0.0% 0.0% 640 0.0% 0.0% 420 0.0% 0.0%
2023.09 2023/05/02 Q2予 35,000 0.0% 0.0% 590 0.0% 0.0% 640 0.0% 0.0% 420 0.0% 0.0%
2023.09 2023/02/01 Q1予 35,000 0.0% 0.0% 590 0.0% 0.0% 640 0.0% 0.0% 420 0.0% 0.0%
2023.09 2022/11/14 当初予 35,000 - - - 590 - - - 640 - - - 420 - - -
2022.09 2022/11/14 37,333 +5.2% +10.5% 944 +38.8% +63.3% 1,003 +37.6% +64.2% 657 +39.5% +51.7%
2022.09 2022/08/01 Q3予 35,500 +5.0% +5.0% 680 +17.6% +17.6% 729 +19.3% +19.3% 471 +8.8% +8.8%
2022.09 2022/05/06 Q2予 33,800 0.0% 0.0% 578 0.0% 0.0% 611 0.0% 0.0% 433 0.0% 0.0%
2022.09 2022/02/01 Q1予 33,800 0.0% 0.0% 578 0.0% 0.0% 611 0.0% 0.0% 433 0.0% 0.0%
2022.09 2021/11/12 当初予 33,800 - - - 578 - - - 611 - - - 433 - - -
2021.09 2021/11/12 36,221 +3.5% +13.9% 713 +30.8% +82.8% 758 +31.8% +78.4% 516 +35.8% +87.6%
2021.09 2021/08/02 修正予 35,000 +10.1% +10.1% 545 +39.7% +39.7% 575 +35.3% +35.3% 380 +38.2% +38.2%
2021.09 2021/05/06 Q2予 31,800 0.0% 0.0% 390 0.0% 0.0% 425 0.0% 0.0% 275 0.0% 0.0%
2021.09 2021/02/01 Q1予 31,800 0.0% 0.0% 390 0.0% 0.0% 425 0.0% 0.0% 275 0.0% 0.0%
2021.09 2020/11/13 当初予 31,800 - - - 390 - - - 425 - - - 275 - - -
2020.09 2020/11/13 31,040 -2.1% -2.1% 361 +14.2% +14.2% 410 +15.5% +15.5% 378 +75.8% +75.8%
2020.09 2020/08/03 Q3予 31,700 0.0% 0.0% 316 0.0% 0.0% 355 0.0% 0.0% 215 0.0% 0.0%
2020.09 2020/05/01 Q2予 31,700 0.0% 0.0% 316 0.0% 0.0% 355 0.0% 0.0% 215 0.0% 0.0%
2020.09 2020/02/03 Q1予 31,700 0.0% 0.0% 316 0.0% 0.0% 355 0.0% 0.0% 215 0.0% 0.0%
2020.09 2019/11/13 当初予 31,700 - - - 316 - - - 355 - - - 215 - - -
2019.09 2019/11/13 31,013 -2.8% -2.8% 283 -9.3% -9.3% 329 -3.2% -3.2% 221 +5.2% +5.2%
2019.09 2019/08/01 Q3予 31,900 0.0% 0.0% 312 0.0% 0.0% 340 0.0% 0.0% 210 0.0% 0.0%
2019.09 2019/05/08 Q2予 31,900 0.0% 0.0% 312 0.0% 0.0% 340 0.0% 0.0% 210 0.0% 0.0%
2019.09 2019/02/01 Q1予 31,900 0.0% 0.0% 312 0.0% 0.0% 340 0.0% 0.0% 210 0.0% 0.0%
2019.09 2018/11/14 当初予 31,900 - - - 312 - - - 340 - - - 210 - - -
2018.09 2018/11/14 31,730 -1.3% -1.3% 292 +11.5% +11.5% 333 +14.4% +14.4% 305 +8.9% +8.9%
2018.09 2018/08/01 Q3予 32,150 0.0% 0.0% 262 0.0% 0.0% 291 0.0% 0.0% 280 0.0% 0.0%
2018.09 2018/02/01 Q1予 32,150 0.0% 0.0% 262 0.0% 0.0% 291 0.0% 0.0% 280 0.0% 0.0%
2018.09 2017/11/14 当初予 32,150 - - - 262 - - - 291 - - - 280 - - -
2017.09 2017/11/14 30,862 -2.0% -2.0% 202 -35.9% -35.9% 242 -29.9% -29.9% 133 -39.5% -39.5%
2017.09 2017/08/01 Q3予 31,500 0.0% 0.0% 315 0.0% 0.0% 345 0.0% 0.0% 220 0.0% 0.0%
2017.09 2017/05/02 Q2予 31,500 0.0% 0.0% 315 0.0% 0.0% 345 0.0% 0.0% 220 0.0% 0.0%
2017.09 2017/02/01 Q1予 31,500 0.0% 0.0% 315 0.0% 0.0% 345 0.0% 0.0% 220 0.0% 0.0%
2017.09 2016/11/14 当初予 31,500 - - - 315 - - - 345 - - - 220 - - -
2016.09 2016/11/14 30,097 -2.3% -2.3% 197 -29.6% -29.6% 232 -24.2% -24.2% 125 -3.8% -3.8%
2016.09 2016/08/01 Q3予 30,800 0.0% 0.0% 280 0.0% 0.0% 306 0.0% 0.0% 130 0.0% 0.0%
2016.09 2016/05/02 Q2予 30,800 0.0% 0.0% 280 0.0% 0.0% 306 0.0% 0.0% 130 0.0% 0.0%
2016.09 2016/02/01 Q1予 30,800 0.0% 0.0% 280 0.0% 0.0% 306 0.0% 0.0% 130 0.0% 0.0%
2016.09 2015/11/16 当初予 30,800 - - - 280 - - - 306 - - - 130 - - -
2015.09 2015/11/16 29,565 -4.3% -4.3% 205 -36.9% -36.9% 240 -30.4% -30.4% 159 -16.3% -16.3%
2015.09 2015/07/31 Q3予 30,900 0.0% 0.0% 325 0.0% 0.0% 345 0.0% 0.0% 190 0.0% 0.0%
2015.09 2015/05/01 Q2予 30,900 0.0% 0.0% 325 0.0% 0.0% 345 0.0% 0.0% 190 0.0% 0.0%
2015.09 2015/01/30 Q1予 30,900 0.0% 0.0% 325 0.0% 0.0% 345 0.0% 0.0% 190 0.0% 0.0%
2015.09 2014/11/14 当初予 30,900 - - - 325 - - - 345 - - - 190 - - -
2014.09 2014/11/14 29,667 - - - 263 - - - 290 - - - 146 - - -
ページトップへ戻る